SCHEMBL3076355

SCHEMBL3076355

CC1(C)C2CCC1(CS(=O)(=O)ON1C(=O)CCC1=O)C(=O)C2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.56
ALDH1A1 P00352 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
MEN1 O00255 2/20 0.53
F2 P00734 2/20 0.52
PRSS1 P07477 2/20 0.52
PRSS2 P07478 2/20 0.52
PRSS3 P35030 2/20 0.52
KDM4E B2RXH2 1/20 0.50
GAA P10253 1/20 0.50
PKM P14618 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA5A P35218 2/20 0.48
CA5B Q9Y2D0 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
TSHR P16473 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135682 1.00 KMT2A (0.56) KMT2AALDH1A1SMN1; SMN2MEN1F2
SCHEMBL8907321 0.87 KMT2A (0.56) KMT2AALDH1A1SMN1; SMN2MEN1F2
SCHEMBL3830397 0.87 KMT2A (0.56) KMT2AALDH1A1SMN1; SMN2MEN1F2
SCHEMBL111905 0.86 KMT2A (0.55) KMT2AALDH1A1SMN1; SMN2MEN1F2
SCHEMBL5552230 0.86 KMT2A (0.55) KMT2AALDH1A1SMN1; SMN2MEN1F2
SCHEMBL13462915 0.83 KMT2A (0.52) KMT2AALDH1A1SMN1; SMN2MEN1F2
SCHEMBL13061579 0.83 KMT2A (0.52) KMT2AALDH1A1SMN1; SMN2MEN1F2
SCHEMBL16519683 0.83 ALDH1A1 (0.55) KMT2AALDH1A1SMN1; SMN2MEN1F2
SCHEMBL14564571 0.83 ALDH1A1 (0.55) KMT2AALDH1A1SMN1; SMN2MEN1F2
SCHEMBL20886057 0.82 KMT2A (0.67) KMT2AALDH1A1SMN1; SMN2MEN1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9104102-B2 Radiation-sensitive resin composition JSR CORPORATION (JP) 2015-08-11 US disclosed
US-20120295198-A1 RADIATION-SENSITIVE RESIN COMPOSITION JSR CORPORATION (JP) 2012-11-22 US disclosed
US-20100266952-A1 CYCLIC COMPOUND, PHOTORESIST BASE, PHOTORESIST COMPOSITION, MICROFABRICATION PROCESS, AND SEMICONDUCTOR DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100266952-A1 CYCLIC COMPOUND, PHOTORESIST BASE, PHOTORESIST COMPOSITION, MICROFABRICATION PROCESS, AND SEMICONDUCTOR DEVICE C1S, CCNL2, CCNT1 KMT2A 737/4885ALDH1A1 2673/4885SMN1; SMN2 3511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.